Effect of treatment (BTX-VIB, BTX-SHAM, VIB, SHAM) on individual muscle masses (mg) 21 days following treatment.

Significant Group x Leg interaction for muscle mass (p2 = 0.81 to 0.96). Significantly lower muscle masses (pa compared with untreated leg; b compared with SHAM and VIB treated legs (partial η2 = 0.93 to 0.99); c compared with BTX-SHAM treated leg (partial η2 = 0.30); d compared with SHAM and VIB untreated leg (partial η2 = 0.95 to 0.97). Values are the mean ± SD (n = 8 for BTX-SHAM and VIB; n = 9 for BTX-VIB; n = 11 for SHAM).